Erdds and Ullmann' reported that streptomycin inhibits the incorporation of labeled amino acids into protein in cell-free preparations of sensitive strains of Mycobacterium friburgensis but not in preparations of resistant strains. More recently Spotts and Stanier2 advanced the hypothesis that streptomycin sensitivity, resistance, or dependence, is the result of modifications in the structure of the ribosomes that affect their affinity for messenger-RNA. They propose that the structure of the ribosomes of sensitive cells endows them with a high affinity for streptomycin and that combination with this antibiotic interferes with the attachment of messenger-RNA with corresponding inhibition of protein synthesis. The ribosomes of resistant cells are supposed to have no affinity for streptomycin; consequently the drug does not affect their function. It had been found by Hancock3 that streptomycin sensitive, but not resistant, bacterial cells can bind small amounts of streptomycin irreversibly.
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We wish to report on experiments showing that inhibition of protein synthesis by streptomycin in cell-free preparations of sensitive strains of Escherichia coli is due to interference of the drug with ribosomal function. Thus, streptomycin decreased the polyuridylic acid (poly U) dependent incorporation of C14-labeled phenylalanine into acid-insoluble products4 in a system containing (a) supernatant and ribosomes of sensitive, or (b) supernatant of resistant and ribosomes of sensitive E. coli. The drug had no effect with (a) supernatant and ribosomes of resistant, or (b) supernatant of sensitive and ribosomes of resistant cells. While these experiments point to the ribosomes as the site of streptomycin sensitivity, in agreement with the view of Spotts and Stanier, they throw no light on the actual mode of action of the drug.
Preparations and Methods.-These were as previously described4 except that the preincubation of the ribosomes with supernatant, cold amino acids, and an adenosine triphosphate generating system, was left out, and for the omission of cold amino acids (only phenylalanine-C14 being present) from the incubation mixture. Addition of ribosomes and streptomycin preceded that of the remaining components of the system. Streptomycin inhibition was less pronounced if the drug was added last. E. coli transfer RNA was added in saturating amounts. The incubation was for 30 minutes at 37°. Poly U, sample 1 (sedimentation coefficient, 10. 3 S), was used. Results.-As shown in Table 1 , the poly U-dependent incorporation of phenylalanine by the system (supernatant and ribosomes) derived from sensitive cells was inhibited approximately 60% by 0.28 X 10-4 M streptomycin with no additional inhibition at 1.4 X 10-4 M. Prior incubation of the ribosomes with streptomycin, up to 30 minutes at 370, did not augment the inhibitory effect of the drug. 0.62 X 10-4 M streptidine, the basic moeity of streptomycin, had no effect. Table 2 shows the result of a typical experiment in which supernatants and ribo- somes derived from streptomycin sensitive and resistant cells were crossed. Streptomycin inhibited the incorporation of phenylalanine whenever ribosomes of the sensitive strain, whether with "sensitive" or "resistant" supernatant, were used. There was no inhibition with "resistant" ribosomes, whether with "resistant" or "sensitive" supernatant. Similar results were' obtained in two other experiments of this kind. The same was true of an experiment, in the absence of poly U, with phenylalanine-C14 and a mixture of the 19 remaining cold amino acids, although the incorporation of phenylalanine was much smaller in this case. This experiment was performed in order to see whether the results with poly U, i.e. with artificial messenger, could be duplicated with natural messenger for, under these conditions, amino acid incorporation is probably made possible by the presence of small amounts of messenger-RNA on the ribosomes. Streptomycin did not seem to act by releasing an inhibitor, e.g., ribonuclease, from "sensitive" ribosomes for, in experiments with mixtures of "sensitive" and "resistant" ribosomes, the degree of inhibition per mg of ribosomal protein decreased to the extent that the former were diluted by the latter. Summary. Streptomycin decreased the polyuridylic acid-dependent incorporation of C'4-labeled phenylalanine into acid-insoluble products in a cell-free system containing ribosomes of streptomycin sensitive E. coli and supernatant of either sensitive or resistant cells. There was no inhibition when the system contained ribosomes of streptomycin resistant E. coli and supernatant of either resistant or sensitive cells. The experiments show that streptomycin interferes with ribosomal function in sensitive bacteria and point to the ribosomes as the site of streptomycin sensitivity. They also show that the genetic locus determining streptomycin sensi tivity is part of a ribosome-specific region of the bacterial chromosome.
We wish to acknowledge the participation of Jerry Atkins and Stanley Leibowitz in this work as "Research Project" students of the class of 1965. 1 Erdds, T., and A. Ullmann, Nature, 183, 618 (1959) . 2 Spotts, C. R., and R. Y. Stanier, Nature, 192, 633 (1961) . 3Hancock, R., Biochem. J., 78, 7P (1961) . 4Lengyel, P., J. F. Speyer, and S. Ochoa, these PROCEEDINGS, 47, 1936 (1961) . Communicated by James Bonner, February 27, 1962 Recent advances in the study of in vitro replication of nucleic acid have indicated that the base composition and perhaps the base sequence of the newly synthesized polymeric nucleic acids are under the specific direction of the template-DNA.1-8 Thus, monomeric nucleoside-triphosphate must interact specifically with the template DNA in order to attain proper alignment of the contiguous monomers during the polymerization process. The high degree of specificity in this interaction, which is perhaps common and basic to all biological systems, raises an interesting luestion as to its chemical mechanism. Since the sugar and phosphate moieties are common to all the nucleoside-triphosphates, the specificity must reside in the variation of the pyridimidine and purine bases. Therefore, it appears to be reasonable to first study the interaction of these bases and their nucleosides with the nucleic acids. Complications due to charge effects of the phosphate groups of the nucleic acids and the triphosphate moieties of the nucleotides are avoided when the bases and the nucleosides are employed. The nucleosides in most cases are preferable to the bases for this type of study because of solubility problems. We are aware also of the fact that the interaction takes place in the presence of enzymes.
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